PF-06291874 Uses, Dosage, Side Effects and more
PF-06291874 is under investigation in clinical trial NCT02175121 (Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of PF-06291874 as Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus).
| Trade Name | PF-06291874 |
| Generic | PF-06291874 |
| Type | |
| Formula | C26H28F3N3O4 |
| Weight | Average: 503.522 Monoisotopic: 503.203190883 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
